By 2030, Evaluate projects five GLP-1s in the top 10 (Mounjaro $36B, Zepbound $25.5B, Ozempic $24.4B, Wegovy $18.1B, plus Cagrisema $15.2B), reshaping metabolic disease with concentrated mega-blockbusters
Use of Aldactone in young children under age 12 is not advised because it can cause serious health issues
A 2025 study published in Psychopharmacology "Semaglutide, Tirzepatide, and Retatrutide Attenuate the Interoceptive Effects of Alcohol in Male and Female Rats" specifically tested all three drugs in animal models
Womens Health in the GLP-1 Era: Are We Better At Losing Weight Now
A continuum may exist whereby lentigo simplex can evolve to form junctional then compound and finally intradermal naevi
Blood thinners like warfarin (Coumadin, Jantoven)